AMRX
Price
$8.42
Change
+$0.05 (+0.60%)
Updated
Jul 3 closing price
Capitalization
1.87B
34 days until earnings call
PAHC
Price
$28.00
Change
+$0.06 (+0.21%)
Updated
Jul 3 closing price
Capitalization
523.71M
54 days until earnings call
Interact to see
Advertisement

AMRX vs PAHC

Header iconAMRX vs PAHC Comparison
Open Charts AMRX vs PAHCBanner chart's image
Amneal Pharmaceuticals
Price$8.42
Change+$0.05 (+0.60%)
Volume$898.79K
Capitalization1.87B
Phibro Animal Health
Price$28.00
Change+$0.06 (+0.21%)
Volume$322.71K
Capitalization523.71M
AMRX vs PAHC Comparison Chart in %
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. PAHC commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a StrongBuy and PAHC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (AMRX: $8.42 vs. PAHC: $28.00)
Brand notoriety: AMRX and PAHC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 47% vs. PAHC: 125%
Market capitalization -- AMRX: $1.87B vs. PAHC: $523.71M
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. PAHC’s [@Pharmaceuticals: Other] market capitalization is $523.71M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whilePAHC’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • PAHC’s FA Score: 1 green, 4 red.
According to our system of comparison, both AMRX and PAHC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 6 TA indicator(s) are bullish while PAHC’s TA Score has 5 bullish TA indicator(s).

  • AMRX’s TA Score: 6 bullish, 4 bearish.
  • PAHC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, AMRX is a better buy in the short-term than PAHC.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а +3.57% price change this week, while PAHC (@Pharmaceuticals: Other) price change was +11.46% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 07, 2025.

PAHC is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than PAHC($524M). AMRX has higher P/E ratio than PAHC: AMRX (90.00) vs PAHC (34.11). PAHC YTD gains are higher at: 34.666 vs. AMRX (6.313). AMRX has higher annual earnings (EBITDA): 400M vs. PAHC (83.7M). PAHC (92.5M) and AMRX (91.5M) have equal amount of cash in the bank . PAHC has less debt than AMRX: PAHC (513M) vs AMRX (2.75B). AMRX has higher revenues than PAHC: AMRX (2.39B) vs PAHC (982M).
AMRXPAHCAMRX / PAHC
Capitalization1.87B524M357%
EBITDA400M83.7M478%
Gain YTD6.31334.66618%
P/E Ratio90.0034.11264%
Revenue2.39B982M244%
Total Cash91.5M92.5M99%
Total Debt2.75B513M536%
FUNDAMENTALS RATINGS
AMRX vs PAHC: Fundamental Ratings
AMRX
PAHC
OUTLOOK RATING
1..100
1522
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
6078
SMR RATING
1..100
9962
PRICE GROWTH RATING
1..100
4638
P/E GROWTH RATING
1..100
2888
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (28) in the Pharmaceuticals Major industry is somewhat better than the same rating for AMRX (90). This means that PAHC’s stock grew somewhat faster than AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (60) in the Pharmaceuticals Major industry is in the same range as PAHC (78). This means that AMRX’s stock grew similarly to PAHC’s over the last 12 months.

PAHC's SMR Rating (62) in the Pharmaceuticals Major industry is somewhat better than the same rating for AMRX (99). This means that PAHC’s stock grew somewhat faster than AMRX’s over the last 12 months.

PAHC's Price Growth Rating (38) in the Pharmaceuticals Major industry is in the same range as AMRX (46). This means that PAHC’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's P/E Growth Rating (28) in the Pharmaceuticals Major industry is somewhat better than the same rating for PAHC (88). This means that AMRX’s stock grew somewhat faster than PAHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXPAHC
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
72%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
69%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
70%
Declines
ODDS (%)
Bearish Trend 30 days ago
78%
Bearish Trend 15 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
68%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIEPX13.90N/A
N/A
Saratoga International Equity I
JPDVX16.44N/A
N/A
JPMorgan Diversified L
AMIDX13.87N/A
N/A
Amana Developing World Institutional
PRPDX67.91N/A
N/A
Permanent Portfolio Permanent A
WBIRX30.67N/A
N/A
William Blair International Growth R6

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with HROW. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then HROW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+0.60%
HROW - AMRX
47%
Loosely correlated
+3.86%
PAHC - AMRX
47%
Loosely correlated
+0.21%
VTRS - AMRX
42%
Loosely correlated
-0.21%
ZTS - AMRX
40%
Loosely correlated
+0.06%
AMPH - AMRX
39%
Loosely correlated
-1.61%
More